A phase II study of 4'-epirubicin in the treatment of poor-risk Kaposi's sarcoma and AIDS.

v1

Type:Journal Article

0 views

[![NobleID](https://www.nobleid.org/api/badge/CDCFE2C4.svg?ark=w1%2F20260515%2FCDCFE2C4)](https://nobleid.org/work/w1/20260515/CDCFE2C4)

ARK Inflections

Bibliometric Analysis

Impact metrics, research fronts, co-authorship networks →

Authors & Claims

Paper Authors